1 |
Pu J, Zhang Y, Wang A, Qin Z, Zhuo C, Li W, Xu Z, Tang Q, Wang J, Wei H. ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis. Front Oncol 2021;11:754835. [PMID: 34733789 DOI: 10.3389/fonc.2021.754835] [Reference Citation Analysis]
|
2 |
Wu Y, Zhou Y, Gao H, Wang Y, Cheng Q, Jian S, Ding Q, Gu W, Yao Y, Ma J, Wu W, Li Y, Tong X, Song X, Ma S. LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism. Oxid Med Cell Longev 2021;2021:9979707. [PMID: 35069968 DOI: 10.1155/2021/9979707] [Reference Citation Analysis]
|